Search

This free 30 minute presentation will cover the spectrum of rhythm control strategies with focused topics, including the recent update to the AF Guidelines, pharmacological treatment options, and the latest thinking on rate vs. rhythm control. A case-based format will be utilized to demonstrate clinical decision pathways and the pros and cons of various therapeutic options, including FDA-approved antiarrhythmic agents.

WASHINGTON, DC — New multicenter research reveals that female patients fail ablation procedures more often than male patients, according to a study published in the February edition of the HeartRhythm Journal, the official journal of the Heat Rhythm Society. The study also shows that males undergo catheter ablation for the treatment of atrial fibrillation five times as often as females and typically with significantly fewer complications.

WASHINGTON, DC — The Heart Rhythm Society applauds the introduction of Senate Resolution SRES 220 which calls for the designation of September as National Atrial Fibrillation (AF) Awareness Month. The resolution reinforces the need to raise awareness and garner support for initiatives affecting AF, a condition that impacts roughly 2.2 million Americans.

WASHINGTON, April 1, 2010 — New findings confirm atrial fibrillation (AF) is independently associated with the risk of all forms of dementia, including Alzheimer’s and other senile and vascular dementia types. According to a study published in the April edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, the presence of atrial fibrillation indicated higher mortality rates in all dementia subtypes; however, mortality risk was most prominent in the youngest population studied.

Over the four days of the meeting all the aspects of cardiac arrhythmias, from epidemiology, to pathophysiology, natural history of heart rhythms, diagnosis, prognosis and treatment, will be simultaneously dealt in 11 different rooms by over 400 invited speakers, all internationally renowned leaders in the field of clinical arrhythmology, electrophysiology and cardiac pacing.

The meeting will present current and future management on sudden cardiac death, new drug and ablation treatment for atrial fibrillation, pacing and ICD advances, cardiac resynchronization techniques, remote patient monitoring, and advances in neuromodulation for heart failure and hypertension. The well received certificate Cardiac Rhythm Management Course will continue, and new courses on EPS/ECG added.

WASHINGTON, DC — The Heart Rhythm Society applauds the introduction of House Resolution 255 which calls for a National Atrial Fibrillation (AF) Awareness Month in September. Introduced by Representative C.A. ‘”Dutch” Ruppersberger (D-MD) and co-sponsored by Kay Granger (R-TX), the resolution will support efforts to raise awareness about AF which impacts approximately 2.2 million Americans each day as well as promote prevention and advance optimal patient care.

WASHINGTON — Does it feel like a fish flopping, thunder rumbling or drums pounding in your chest?  If so, you may be suffering from a serious heart condition called Atrial Fibrillation (AF).  To help potential AF sufferers make that connection, the Heart Rhythm Society (HRS) is kicking off AF Awareness Month with the “A-Fib Feels Like” campaign. 

WASHINGTON — According to a new survey issued by the Heart Rhythm Society, the majority of Americans are unaware of two serious and potentially life-threatening heart rhythm disorders, atrial fibrillation (AF) and sudden cardiac arrest (SCA). In fact, only one in three Americans have ever heard of AF or recognize the number of lives claimed each year from SCA. Throughout February, Heart Health Month, the Heart Rhythm Society spotlights the need for public education on heart rhythm disorders affecting millions of people, and the specialists best suited to treat them – electrophysiologists.

WASHINGTON —  The Heart Rhythm Society (HRS), written in joint partnership with European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS), issues an international consensus statement on indications, techniques and outcomes of catheter and surgical ablation of atrial fibrillation (AF).

Washington – The Heart Rhythm Society (HRS), the international leader in science, education and advocacy for cardiac arrhythmia professionals and patients, has been named a Bronze winner in the “Health & Wellness” category of the 33rd Annual Telly Awards for its Sudden Cardiac Arrest (SCA) Patient Education DVD. HRS was selected among great competition as this year’s Annual Telly Awards received over 12,000 entries from all 50 states and five continents.

Today, the Heart Rhythm Society (HRS) in joint partnership with the European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Society (ECAS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) issued an international consensus statement that provides a state-of-the-art review of the indications, techniques, and outcomes of catheter and surgical ablation of atrial fibrillation (AF). The 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, first issued in 2007, and again in 2012, represents a state-of-the art review of the field of catheter and surgical ablation of AF. This document is a complete and comprehensive revision of the 2012 statement and was presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.  

In November 2014, the Heart Rhythm Society (HRS) and National Stroke Association, in collaboration with Boehringer Ingelheim (BI), shared results from a survey of more than 1,200 respondents to evaluate the impact of AFib and stroke on patients and caregivers, and the concurrent perceptions physicians have about treatment options and their patients’ understanding of issues surrounding the condition.

March 28, 2014 - A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society; developed in collaboration with the Society of Thoracic Surgeons.  The goal of this guideline is to establish revised guidelines for optimum management of atrial fibrillation. This guideline supersedes the "2006 ACC/AHA/ESC Guideline for the Management of Patients with Atrial Fibrillation" and the two subsequent focused updates from 2011.

This document has been retired and replaced by the 2017 publication available at this link.

March 2012 — The purpose of the 2012 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AFib. It reports  on the findings of a Task Force, convened by the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the European Cardiac Arrhythmia Society (ECAS) and charged with defining the indications, techniques, and outcomes of this procedure.

February 14, 2011 — This guideline update, states that dabigatran, a new antithrombotic agent that was recently approved by the U.S. Food and Drug Administration, is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation. The update is a joint publication of the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), and the Heart Rhythm Society (HRS). 

This document has been retired and replaced by "2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation."

April 2003 — This consensus statement provides a simple way to characterize an episode of Atrial Fibrillation. It is the result of a collaborative project of the Working Group on Arrhythmias and the Working Group of Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, now known as Heart Rhythm Society.

November 18, 2014 - The Heart Rhythm Society convened a research symposium on December 9–10, 2013, in Washington, DC, that focused on the prevention of atrial fibrillation (AF) as well as AF-related stroke and morbidity.Attendees sought to summarize advances in understanding AF since a 2008 National Institutes of Health(NIH) conference on this topic and to identify continued knowledge gaps and current research priorities.  This resultant whitepaper was developed in collaboration with and endorsed by the European Heart Rhythm Association (EHRA) and the Canadian Heart Rhythm Society (CHRS). It summarizes the deliberations of the attendees in an effort to accelerate progress toward preventing AF and its consequences.

June 29, 2015 - The American College of Cardiology (ACC), the Heart Rhythm Society (HRS), and the Society for Cardiovascular Angiography and Interventions (SCAI) have collaborated in writing this overview as the first of a series of documents to address issues critical to the appropriate integration of new technologies into the care of patients with AF. 

August 15, 2006 — A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines

This document has been retired and replaced by "2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation."